Combination Chemotherapy in Advanced Adrenocortical CarcinomaMartin Faßnacht, Britt Skogseid, André Lacroix et al.|New England Journal of Medicine|2012Cited by 863
Unintended Consequences of Expensive Cancer Therapeutics—The Pursuit of Marginal Indications and a Me-Too Mentality That Stifles Innovation and CreativityTito Fojo, Andrew W. Lo, Sham Mailankody|JAMA Otolaryngology–Head & Neck Surgery|2014Cited by 301
The VEGF Inhibitor Axitinib Has Limited Effectiveness as a Therapy for Adrenocortical CancerCiara C. O’Sullivan, Tito Fojo|The Journal of Clinical Endocrinology & Metabolism|2014Cited by 98
Lessons from withdrawn accelerated approvals in oncologyGeorge Mellgard, Susan E. Bates, Tito Fojo|Nature Cancer|2024Cited by 11